The role of immune and inflammatory cells in idiopathic pulmonary fibrosis

O Desai, J Winkler, M Minasyan, EL Herzog - Frontiers in medicine, 2018 - frontiersin.org
The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly
understood. While most sources agree that IPF does not result from a primary …

Emerging targets of disease-modifying therapy for systemic sclerosis

ER Volkmann, J Varga - Nature Reviews Rheumatology, 2019 - nature.com
Systemic sclerosis (SSc) has the highest cause-specific mortality of all the connective tissue
diseases, and the aetiology of this complex and heterogeneous condition remains an …

Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis

C Ryu, H Sun, M Gulati, JD Herazo-Maya… - American journal of …, 2017 - atsjournals.org
Rationale: Idiopathic pulmonary fibrosis (IPF) involves the accumulation of α-smooth muscle
actin–expressing myofibroblasts arising from interactions with soluble mediators such as …

Biomarkers in idiopathic pulmonary fibrosis

F Drakopanagiotakis, L Wujak, M Wygrecka, P Markart - Matrix Biology, 2018 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease leading to
respiratory failure and ultimately to death. Being the prototype of interstitial lung diseases …

PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses

M Bueno, D Zank, I Buendia-Roldán, K Fiedler… - PLoS …, 2019 - journals.plos.org
We have previously shown that endoplasmic reticulum stress (ER stress) represses the
PTEN inducible kinase 1 (PINK1) in lung type II alveolar epithelial cells (AECII) reducing …

[HTML][HTML] Molecular and genetic biomarkers in idiopathic pulmonary fibrosis: where are we now?

I Tomos, I Roussis, AM Matthaiou, K Dimakou - Biomedicines, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) represents a chronic progressive fibrotic interstitial lung
disease of unknown cause with an ominous prognosis. It remains an unprecedent clinical …

Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis

RC Russo, VFJ Quesniaux, B Ryffel - Trends in Immunology, 2023 - cell.com
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic interstitial lung disease (ILD) that affects
lung mechanical functions and gas exchange. IPF is caused by increased fibroblast activity …

The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis

SJ Kim, P Cheresh, RP Jablonski, DB Williams… - International journal of …, 2015 - mdpi.com
Convincing evidence has emerged demonstrating that impairment of mitochondrial function
is critically important in regulating alveolar epithelial cell (AEC) programmed cell death …

Neutrophil extracellular traps activate lung fibroblast to induce polymyositis‐related interstitial lung diseases via TLR9‐miR‐7‐Smad2 pathway

S Zhang, X Jia, Q Zhang, L Zhang… - Journal of Cellular …, 2020 - Wiley Online Library
Excessive neutrophil extracellular trap (NET) formation may contribute to polymyositis (PM)‐
associated interstitial lung diseases (ILD), but the underlying mechanism is not fully …

Heterogeneity of fibroblasts and myofibroblasts in pulmonary fibrosis

DM Habiel, CM Hogaboam - Current pathobiology reports, 2017 - Springer
Abstract Purpose of Review Idiopathic pulmonary fibrosis (IPF) is the most common form of
interstitial lung disease of unknown etiopathogenesis with mean survival of 3–5 years and …